Skip to content
26 October · 06:30 UTCFollow AstraZeneca by emailFollow

AZN · story · 8 October – 12 October

AstraZeneca AI biologics discovery collaboration

AstraZeneca · 4 headlines from 4 outlets, from 8 October 2026 to 12 October 2026.

AstraZeneca dashboard

The story

+6.1strongly positive
Headlines4
Outlets4
Days38 October – 12 October

Carterra and AstraZeneca have announced a drug discovery collaboration based on the lab-in-the-loop approach.

Tone by day

Average of each day's headlines, −10 to +10.

Source: MarketFrame news analysis

Tone by day. Average of each day's headlines, −10 to +10. Source: MarketFrame news analysis
dayAverage tone
8 Oct5.4
11 Oct8.5
12 Oct5.0

The story's tone is the average of its headlines' own scores. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.

How each outlet covered it · 4 outlets

Every outlet, by impact on the tone

Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone.

Source: MarketFrame news analysis

Every outlet, by impact on the tone. Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone. Source: MarketFrame news analysis
outletAverage tone
Yahoo Finance8.5
Dealroom5.8
Simply Wall Street5.0
BioSpace5.0
OutletHeadlinesAverage tone
Yahoo Finance1+8.5
Dealroom1+5.8
Simply Wall Street1+5.0
BioSpace1+5.0

One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.

Day by day · 3 days, strongest headlines first

Monday 12 October 20261 headline · Simply Wall Street discusses AstraZeneca's AI drug discovery push.+5.0
ToneWhat the article reported, and why it scored that waySource
+5.0AI drug discovery push framed as undervalued narrative.Simply Wall Street (opens the article) ↗
AstraZeneca on 12 October
Sunday 11 October 20261 headline · AstraZeneca is putting AI into biologics labs through a new discovery tie-up.+8.5
ToneWhat the article reported, and why it scored that waySource
+8.5New AI discovery partnership for biologics labs is a positive development.Yahoo Finance (opens the article) ↗
AstraZeneca on 11 October
Thursday 8 October 20262 headlines · Carterra and AstraZeneca have announced a drug discovery collaboration based on the lab-in-the-loop approach.+5.4
ToneWhat the article reported, and why it scored that waySource
+5.8New AI drug discovery collaboration involving AstraZenecaDealroom (opens the article) ↗
+5.0Carterra collaboration on drug discoveryBioSpace (opens the article) ↗
AstraZeneca on 8 October

Follow by email

A short, free morning email on how the news treated AstraZeneca: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.

How it works. Every morning an AI model reads the UK business news about each FTSE 100 company and scores how good or bad it is for the company, from −10 to +10. Pages update by about 07:45 UK time.

Not investment advice. MarketFrame rates the tone of news coverage. It is general information, not a recommendation to buy or sell anything. The scores are not share-price data or forecasts: a good score doesn't mean a share will rise, and a bad one doesn't mean it will fall.

Data to 06:30 UTC, 26 October · 326 headlines · 63 companiesMade by Adapt Progress Evolve Limited, a UK company · Privacy · Terms · RSS · API · llms.txt